Published in J Med Chem on November 12, 2009
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature (2016) 2.86
Quantifying the chemical beauty of drugs. Nat Chem (2012) 2.36
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. J Am Chem Soc (2010) 2.30
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc Natl Acad Sci U S A (2010) 2.01
Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol (2010) 1.76
Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel (2010) 1.74
Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. Nat Chem Biol (2010) 1.64
An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov (2015) 1.62
Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun (2010) 1.52
Investigating the Influence of (Deoxy)fluorination on the Lipophilicity of Non-UV-Active Fluorinated Alkanols and Carbohydrates by a New log P Determination Method. Angew Chem Int Ed Engl (2015) 1.40
Simple organic molecules as catalysts for enantioselective synthesis of amines and alcohols. Nature (2013) 1.34
Route to three-dimensional fragments using diversity-oriented synthesis. Proc Natl Acad Sci U S A (2011) 1.33
The influence of the 'organizational factor' on compound quality in drug discovery. Nat Rev Drug Discov (2011) 1.32
Remodelling of the natural product fumagillol employing a reaction discovery approach. Nat Chem (2011) 1.30
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds. J Cheminform (2011) 1.28
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries. J Org Chem (2012) 1.24
Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections. Proc Natl Acad Sci U S A (2011) 1.20
Natural-product-derived fragments for fragment-based ligand discovery. Nat Chem (2012) 1.17
Photoredox Cross-Coupling: Ir/Ni Dual Catalysis for the Synthesis of Benzylic Ethers. Org Lett (2015) 1.16
Inflation of correlation in the pursuit of drug-likeness. J Comput Aided Mol Des (2013) 1.16
Chemical predictive modelling to improve compound quality. Nat Rev Drug Discov (2013) 1.13
A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nat Chem (2013) 1.12
The essential roles of chemistry in high-throughput screening triage. Future Med Chem (2014) 1.12
Multicomponent assembly and diversification of novel heterocyclic scaffolds derived from 2-arylpiperidines. Org Lett (2011) 1.09
1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity. Chem Biol Drug Des (2010) 1.07
Structurally and stereochemically diverse tetrahydropyran synthesis through oxidative C-H bond activation. Angew Chem Int Ed Engl (2010) 1.07
Proton donor acidity controls selectivity in nonaromatic nitrogen heterocycle synthesis. Science (2013) 1.06
Classification of scaffold-hopping approaches. Drug Discov Today (2011) 1.04
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. Sci Rep (2015) 1.03
Fragment-based domain shuffling approach for the synthesis of pyran-based macrocycles. Proc Natl Acad Sci U S A (2011) 1.03
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angew Chem Int Ed Engl (2015) 0.99
Discovery of new antimalarial chemotypes through chemical methodology and library development. Proc Natl Acad Sci U S A (2011) 0.99
Synthesis of a novel suppressor of beta-cell apoptosis via diversity-oriented synthesis. ACS Med Chem Lett (2011) 0.98
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors. Bioorg Med Chem Lett (2013) 0.95
FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res (2015) 0.94
Diversity-oriented synthesis of macrocyclic peptidomimetics. Proc Natl Acad Sci U S A (2011) 0.94
Synthesis and minisci reactions of organotrifluoroborato building blocks. J Org Chem (2013) 0.93
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation. Chem Biol (2013) 0.92
Rational methods for the selection of diverse screening compounds. ACS Chem Biol (2011) 0.92
Regio- and stereoselective 1,2-dihydropyridine alkylation/addition sequence for the synthesis of piperidines with quaternary centers. Angew Chem Int Ed Engl (2014) 0.92
Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology. ACS Med Chem Lett (2015) 0.91
Probing chemical space with alkaloid-inspired libraries. Nat Chem (2014) 0.91
Systems pharmacology. Mt Sinai J Med (2010) 0.90
Reductive cross-coupling of 3-bromo-2,1-borazaronaphthalenes with alkyl iodides. Org Lett (2014) 0.88
Complementary regioselectivity in Rh(III)-catalyzed insertions of potassium vinyltrifluoroborate via C-H activation: preparation and use of 4-trifluoroboratotetrahydroisoquinolones. Org Lett (2013) 0.88
Build/couple/pair strategy for the synthesis of stereochemically diverse macrolactams via head-to-tail cyclization. ACS Comb Sci (2012) 0.88
Accessing Stereochemically Rich Sultams via Microwave-Assisted, Continuous Flow Organic Synthesis (MACOS) Scale-out. J Flow Chem (2011) 0.87
Synthesis and applications of rhodacyclopentanones derived from C-C bond activation. Chem Commun (Camb) (2016) 0.87
Modulation of gamma-secretase for the treatment of Alzheimer's disease. Int J Alzheimers Dis (2012) 0.86
Iterative protecting group-free cross-coupling leading to chiral multiply arylated structures. Nat Commun (2016) 0.86
Metallaphotoredox-catalysed sp(3)-sp(3) cross-coupling of carboxylic acids with alkyl halides. Nature (2016) 0.85
Photoassisted synthesis of enantiopure alkaloid mimics possessing unprecedented polyheterocyclic cores. J Am Chem Soc (2013) 0.85
Radical [3 + 2]-annulation of divinylcyclopropanes: rapid synthesis of complex meloscine analogs. Org Lett (2013) 0.84
Enantioselective functionalization of allylic C-H bonds following a strategy of functionalization and diversification. J Am Chem Soc (2013) 0.84
Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery. PLoS One (2012) 0.84
γ-Secretase Modulators: Can We Combine Potency with Safety? Int J Alzheimers Dis (2012) 0.84
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep (2017) 0.83
Convergent Synthesis of Diverse Tetrahydropyridines via Rh(I)-Catalyzed C-H Functionalization Sequences. Org Process Res Dev (2014) 0.83
Two- and three-dimensional rings in drugs. Chem Biol Drug Des (2014) 0.83
Cycloadditions of cyclohexynes and cyclopentyne. J Am Chem Soc (2014) 0.83
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate. ACS Med Chem Lett (2014) 0.83
Synthesis and applications of α-trifluoromethylated alkylboron compounds. Angew Chem Int Ed Engl (2013) 0.83
Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1). ACS Med Chem Lett (2014) 0.83
Plane of best fit: a novel method to characterize the three-dimensionality of molecules. J Chem Inf Model (2012) 0.83
Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter. Parasitology (2013) 0.82
Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties. J Med Chem (2014) 0.82
A universal isocyanide for diverse heterocycle syntheses. Org Lett (2014) 0.82
Evolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversification. Org Biomol Chem (2014) 0.82
Development of Enantiospecific Coupling of Secondary and Tertiary Boronic Esters with Aromatic Compounds. J Am Chem Soc (2016) 0.81
Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens. Pharmacol Res (2013) 0.81
Direct synthesis of imino-C-nucleoside analogues and other biologically active iminosugars. Nat Commun (2015) 0.81
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products. PLoS One (2013) 0.81
A steric tethering approach enables palladium-catalysed C-H activation of primary amino alcohols. Nat Chem (2015) 0.80
Transition metal-catalyzed alkyl-alkyl bond formation: Another dimension in cross-coupling chemistry. Science (2017) 0.80
Real-Time Biological Annotation of Synthetic Compounds. J Am Chem Soc (2016) 0.80
Generation and regioselective trapping of a 3,4-piperidyne for the synthesis of functionalized heterocycles. J Am Chem Soc (2015) 0.80
Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. J Chem Inf Model (2013) 0.80
Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries. Methods Mol Biol (2015) 0.80
Amino Azaxylylenes Photogenerated from o-Amido Imines: Photoassisted Access to Complex Spiro-Poly-Heterocycles. Angew Chem Int Ed Engl (2015) 0.79
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity. PLoS Negl Trop Dis (2015) 0.79
Yeast synthetic biology platform generates novel chemical structures as scaffolds for drug discovery. ACS Synth Biol (2014) 0.79
Peptide-ligand binding modeling of siRNA with cell-penetrating peptides. Biomed Res Int (2014) 0.78
Redox cycloisomerization approach to 1,2-dihydropyridines. Org Lett (2015) 0.78
Mechanism of scrapie prion precipitation with phosphotungstate anions. ACS Chem Biol (2015) 0.78
Optimization of Arylamides as Novel, Potent and Brain-penetrant Antiprion Lead Compounds. ACS Med Chem Lett (2013) 0.78
Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Med Chem Lett (2014) 0.78
Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorg Med Chem Lett (2015) 0.78
Partially Saturated Bicyclic Heteroaromatics as an sp(3) -Enriched Fragment Collection. Angew Chem Int Ed Engl (2016) 0.78
Recent developments in the use of aza-Heck cyclizations for the synthesis of chiral N-heterocycles. Chem Sci (2017) 0.78
Catalytic Kinetic Resolution of Disubstituted Piperidines by Enantioselective Acylation: Synthetic Utility and Mechanistic Insights. J Am Chem Soc (2015) 0.78
Biofragments: an approach towards predicting protein function using biologically related fragments and its application to Mycobacterium tuberculosis CYP126. Chembiochem (2014) 0.77
Multicomponent, Mannich-type assembly process for generating novel, biologically-active 2-arylpiperidines and derivatives. Tetrahedron (2014) 0.77
Development and implementation of (Q)SAR modeling within the CHARMMing web-user interface. J Comput Chem (2014) 0.77
Drug discovery: Diversifying complexity. Nat Chem (2013) 0.77
Regio- and Diastereoselective Synthesis of Highly Substituted, Oxygenated Piperidines from Tetrahydropyridines. J Org Chem (2015) 0.77
Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose? Angew Chem Int Ed Engl (2016) 0.77
Irreversible endo-selective diels-alder reactions of substituted alkoxyfurans: a general synthesis of endo-cantharimides. Chemistry (2015) 0.77
Epothilones: From discovery to clinical trials. Curr Top Med Chem (2014) 0.77
Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex. J Med Chem (2016) 0.77
Atropisomeric [(diphosphine)Au2 Cl2 ] complexes and their catalytic activity towards asymmetric cycloisomerisation of 1,6-enynes. Chemistry (2014) 0.77
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Comparison of several molecular docking programs: pose prediction and virtual screening accuracy. J Chem Inf Model (2009) 1.77
Investigation of MM-PBSA rescoring of docking poses. J Chem Inf Model (2008) 1.11
Insights for predicting blood-brain barrier penetration of CNS targeted molecules using QSPR approaches. J Chem Inf Model (2010) 0.97
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism. J Comput Aided Mol Des (2010) 0.88
An enriched structural kinase database to enable kinome-wide structure-based analyses and drug discovery. Protein Sci (2010) 0.88
Lead optimization via high-throughput molecular docking. Curr Opin Drug Discov Devel (2007) 0.87
Computational alanine scanning with linear scaling semiempirical quantum mechanical methods. Proteins (2010) 0.87
Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability. J Comput Aided Mol Des (2009) 0.85
Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonists. Proteins (2010) 0.81
Direct oxa-Pictet-Spengler cyclization to the natural (3a,5)-trans-stereochemistry in the syntheses of (+)-7-deoxyfrenolicin B and (+)-7-deoxykalafungin. J Org Chem (2009) 0.81
Chemical space sampling by different scoring functions and crystal structures. J Comput Aided Mol Des (2010) 0.80
CLIP: similarity searching of 3D databases using clique detection. J Chem Inf Comput Sci (2003) 0.79
Computation of 3D queries for ROCS based virtual screens. J Comput Aided Mol Des (2009) 0.79
A structural informatics approach to mine kinase knowledge bases. Drug Discov Today (2009) 0.78
Chemical space sampling in virtual screening by different crystal structures. Chem Biol Drug Des (2010) 0.77
CONFIRM: connecting fragments found in receptor molecules. J Comput Aided Mol Des (2008) 0.77
A protein relational database and protein family knowledge bases to facilitate structure-based design analyses. Chem Biol Drug Des (2010) 0.76
Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1). Bioorg Med Chem (2002) 0.76
RNA unrestrained molecular dynamics ensemble improves agreement with experimental NMR data compared to single static structure: a test case. J Comput Aided Mol Des (2006) 0.75
GARD: a Generally Applicable Replacement for RMSD. J Chem Inf Model (2009) 0.75
Biased retrieval of chemical series in receptor-based virtual screening. J Comput Aided Mol Des (2010) 0.75